Loading…

Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog

This study was undertaken to determine the role of cholecystokinin in pancreatic enzyme secretion stimulated by bombesin and a meal by (a) comparing the pancreatic enzyme output during bombesin infusion and after a meal to output during caerulein infusion and (b) comparing the inhibitory effect of t...

Full description

Saved in:
Bibliographic Details
Published in:Gut 1991-02, Vol.32 (2), p.215-219
Main Authors: de Jong, A J, Singer, M V, Jansen, J B, Niebel, W, Rovati, L C, Lamers, C B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b4225-89741b99ca04633ee711c1306131cd388a6eb32a7cfc4b80677fc4bc7d71ac283
cites cdi_FETCH-LOGICAL-b4225-89741b99ca04633ee711c1306131cd388a6eb32a7cfc4b80677fc4bc7d71ac283
container_end_page 219
container_issue 2
container_start_page 215
container_title Gut
container_volume 32
creator de Jong, A J
Singer, M V
Jansen, J B
Niebel, W
Rovati, L C
Lamers, C B
description This study was undertaken to determine the role of cholecystokinin in pancreatic enzyme secretion stimulated by bombesin and a meal by (a) comparing the pancreatic enzyme output during bombesin infusion and after a meal to output during caerulein infusion and (b) comparing the inhibitory effect of the cholecystokinin-receptor antagonist lorglumide (CR-1409) on enzyme output in response to bombesin and food with the response to caerulein. Bombesin (90 pmol/kg per h) and caerulein (30 pmol/kg per h) were infused into seven dogs in doses giving similar plasma cholecystokinin peak increments as a meal (mean (SEM) 6.8 (0.8), 6.3 (1.2), and 5.7 (0.8) pM, respectively), together with either saline or 2 mg/kg per h of lorglumide. A background infusion of synthetic secretin 20.5 pmol/kg per h was given in each experiment. In addition, gastric acid secretion was determined in the experiments with bombesin and caerulein infusion. Pancreatic protein responses to bombesin (1231 (247) mg/h) and food (1430 (220) mg/h) were similar to the responses to caerulein (1249 (201) mg/h). Lorglumide inhibited pancreatic protein output during stimulation with bombesin by 60%, after the meal by 45%, and during caerulein infusion by 68%. Pancreatic bicarbonate output by bombesin, caerulein, and food was inhibited by lorglumide by 28%, 40%, and 38%, respectively. In contrast, lorglumide significantly increased gastric acid secretion from 1.12 to 7.98 mmol/h during bombesin infusion and from 0.52 to 7.62 mmol/h during caerulein infusion. In conclusion, cholecystokinin plays an important part in the stimulation of pancreatic enzyme secretion by bombesin and a meal in conscious dogs and it is involved in the regulation of gastric acid during stimulation by infusions of caerulein and bombesin.
doi_str_mv 10.1136/gut.32.2.215
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1378812</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80725333</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4225-89741b99ca04633ee711c1306131cd388a6eb32a7cfc4b80677fc4bc7d71ac283</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhSMEKmVgxxbJEgI2k8GOk9jZIMGo_EhVWVDYWo5zk_HUsae2UzE8IY-FRxm10AW-C1v3fDo-lm-WPSd4RQit3w5TXNFilYpUD7JTUtY8pwXnD7NTjAnLK1Y2j7MnIWwxxpw35CQ7Ibwuq7I6zX6f9T2oiFyP4gaQ2jgDah-iu9JW29yDgl10Hkkb5eCsDhEZ5wczjboD5CzaSas8yKgVAvtrPwIKkBpRJy1EPU5GRuhQu0etG1sI2i5R71y3TJYdUhL8ZODQHPSNtgMKetRGerQzMozyfiCknFVgo5eHCwJKnUPszg1Ps0e9NAGeHfdF9v3j2eX6c37-9dOX9fvzvC2Losp5w0rSNo2SuKwpBWCEKEJxTShRHeVc1tDSQjLVq7LluGbscFCsY0SqgtNF9m723U3tCN0cxoid16P0e-GkFv8qVm_E4G4EoYxzUiSD10cD764nCFGMOigwRlpwUxAcs6KiaS2yl_fArZu8TY8ThDGM6wJznKjlTCnvQvDQ30YhWBzmQ6T5ELQQqUiV8Bd_x7-D54FI-qujLoOSpvfpe3W4w5q64LhoEpfPXJoI-HmrS38lakZZJS5-rMU3ij9c8ou1WCf-zcy34_b_Cf8AIvnlbA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770062080</pqid></control><display><type>article</type><title>Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog</title><source>Open Access: PubMed Central</source><creator>de Jong, A J ; Singer, M V ; Jansen, J B ; Niebel, W ; Rovati, L C ; Lamers, C B</creator><creatorcontrib>de Jong, A J ; Singer, M V ; Jansen, J B ; Niebel, W ; Rovati, L C ; Lamers, C B</creatorcontrib><description>This study was undertaken to determine the role of cholecystokinin in pancreatic enzyme secretion stimulated by bombesin and a meal by (a) comparing the pancreatic enzyme output during bombesin infusion and after a meal to output during caerulein infusion and (b) comparing the inhibitory effect of the cholecystokinin-receptor antagonist lorglumide (CR-1409) on enzyme output in response to bombesin and food with the response to caerulein. Bombesin (90 pmol/kg per h) and caerulein (30 pmol/kg per h) were infused into seven dogs in doses giving similar plasma cholecystokinin peak increments as a meal (mean (SEM) 6.8 (0.8), 6.3 (1.2), and 5.7 (0.8) pM, respectively), together with either saline or 2 mg/kg per h of lorglumide. A background infusion of synthetic secretin 20.5 pmol/kg per h was given in each experiment. In addition, gastric acid secretion was determined in the experiments with bombesin and caerulein infusion. Pancreatic protein responses to bombesin (1231 (247) mg/h) and food (1430 (220) mg/h) were similar to the responses to caerulein (1249 (201) mg/h). Lorglumide inhibited pancreatic protein output during stimulation with bombesin by 60%, after the meal by 45%, and during caerulein infusion by 68%. Pancreatic bicarbonate output by bombesin, caerulein, and food was inhibited by lorglumide by 28%, 40%, and 38%, respectively. In contrast, lorglumide significantly increased gastric acid secretion from 1.12 to 7.98 mmol/h during bombesin infusion and from 0.52 to 7.62 mmol/h during caerulein infusion. In conclusion, cholecystokinin plays an important part in the stimulation of pancreatic enzyme secretion by bombesin and a meal in conscious dogs and it is involved in the regulation of gastric acid during stimulation by infusions of caerulein and bombesin.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>EISSN: 1458-3288</identifier><identifier>DOI: 10.1136/gut.32.2.215</identifier><identifier>PMID: 1864545</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Animals ; Bicarbonates - metabolism ; Biological and medical sciences ; Bombesin - pharmacology ; Ceruletide - pharmacology ; Cholecystokinin - antagonists &amp; inhibitors ; Cholecystokinin - blood ; Dogs ; Eating - physiology ; Exocrine pancreas ; Female ; Fundamental and applied biological sciences. Psychology ; Gastric Acid - metabolism ; Pancreas - enzymology ; Proglumide - analogs &amp; derivatives ; Proglumide - pharmacology ; Proteins - metabolism ; Vertebrates: digestive system</subject><ispartof>Gut, 1991-02, Vol.32 (2), p.215-219</ispartof><rights>1991 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Feb 1991</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4225-89741b99ca04633ee711c1306131cd388a6eb32a7cfc4b80677fc4bc7d71ac283</citedby><cites>FETCH-LOGICAL-b4225-89741b99ca04633ee711c1306131cd388a6eb32a7cfc4b80677fc4bc7d71ac283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1378812/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1378812/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19628029$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1864545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Jong, A J</creatorcontrib><creatorcontrib>Singer, M V</creatorcontrib><creatorcontrib>Jansen, J B</creatorcontrib><creatorcontrib>Niebel, W</creatorcontrib><creatorcontrib>Rovati, L C</creatorcontrib><creatorcontrib>Lamers, C B</creatorcontrib><title>Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog</title><title>Gut</title><addtitle>Gut</addtitle><description>This study was undertaken to determine the role of cholecystokinin in pancreatic enzyme secretion stimulated by bombesin and a meal by (a) comparing the pancreatic enzyme output during bombesin infusion and after a meal to output during caerulein infusion and (b) comparing the inhibitory effect of the cholecystokinin-receptor antagonist lorglumide (CR-1409) on enzyme output in response to bombesin and food with the response to caerulein. Bombesin (90 pmol/kg per h) and caerulein (30 pmol/kg per h) were infused into seven dogs in doses giving similar plasma cholecystokinin peak increments as a meal (mean (SEM) 6.8 (0.8), 6.3 (1.2), and 5.7 (0.8) pM, respectively), together with either saline or 2 mg/kg per h of lorglumide. A background infusion of synthetic secretin 20.5 pmol/kg per h was given in each experiment. In addition, gastric acid secretion was determined in the experiments with bombesin and caerulein infusion. Pancreatic protein responses to bombesin (1231 (247) mg/h) and food (1430 (220) mg/h) were similar to the responses to caerulein (1249 (201) mg/h). Lorglumide inhibited pancreatic protein output during stimulation with bombesin by 60%, after the meal by 45%, and during caerulein infusion by 68%. Pancreatic bicarbonate output by bombesin, caerulein, and food was inhibited by lorglumide by 28%, 40%, and 38%, respectively. In contrast, lorglumide significantly increased gastric acid secretion from 1.12 to 7.98 mmol/h during bombesin infusion and from 0.52 to 7.62 mmol/h during caerulein infusion. In conclusion, cholecystokinin plays an important part in the stimulation of pancreatic enzyme secretion by bombesin and a meal in conscious dogs and it is involved in the regulation of gastric acid during stimulation by infusions of caerulein and bombesin.</description><subject>Animals</subject><subject>Bicarbonates - metabolism</subject><subject>Biological and medical sciences</subject><subject>Bombesin - pharmacology</subject><subject>Ceruletide - pharmacology</subject><subject>Cholecystokinin - antagonists &amp; inhibitors</subject><subject>Cholecystokinin - blood</subject><subject>Dogs</subject><subject>Eating - physiology</subject><subject>Exocrine pancreas</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gastric Acid - metabolism</subject><subject>Pancreas - enzymology</subject><subject>Proglumide - analogs &amp; derivatives</subject><subject>Proglumide - pharmacology</subject><subject>Proteins - metabolism</subject><subject>Vertebrates: digestive system</subject><issn>0017-5749</issn><issn>1468-3288</issn><issn>1458-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNp9ks1u1DAUhSMEKmVgxxbJEgI2k8GOk9jZIMGo_EhVWVDYWo5zk_HUsae2UzE8IY-FRxm10AW-C1v3fDo-lm-WPSd4RQit3w5TXNFilYpUD7JTUtY8pwXnD7NTjAnLK1Y2j7MnIWwxxpw35CQ7Ibwuq7I6zX6f9T2oiFyP4gaQ2jgDah-iu9JW29yDgl10Hkkb5eCsDhEZ5wczjboD5CzaSas8yKgVAvtrPwIKkBpRJy1EPU5GRuhQu0etG1sI2i5R71y3TJYdUhL8ZODQHPSNtgMKetRGerQzMozyfiCknFVgo5eHCwJKnUPszg1Ps0e9NAGeHfdF9v3j2eX6c37-9dOX9fvzvC2Losp5w0rSNo2SuKwpBWCEKEJxTShRHeVc1tDSQjLVq7LluGbscFCsY0SqgtNF9m723U3tCN0cxoid16P0e-GkFv8qVm_E4G4EoYxzUiSD10cD764nCFGMOigwRlpwUxAcs6KiaS2yl_fArZu8TY8ThDGM6wJznKjlTCnvQvDQ30YhWBzmQ6T5ELQQqUiV8Bd_x7-D54FI-qujLoOSpvfpe3W4w5q64LhoEpfPXJoI-HmrS38lakZZJS5-rMU3ij9c8ou1WCf-zcy34_b_Cf8AIvnlbA</recordid><startdate>19910201</startdate><enddate>19910201</enddate><creator>de Jong, A J</creator><creator>Singer, M V</creator><creator>Jansen, J B</creator><creator>Niebel, W</creator><creator>Rovati, L C</creator><creator>Lamers, C B</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19910201</creationdate><title>Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog</title><author>de Jong, A J ; Singer, M V ; Jansen, J B ; Niebel, W ; Rovati, L C ; Lamers, C B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4225-89741b99ca04633ee711c1306131cd388a6eb32a7cfc4b80677fc4bc7d71ac283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Animals</topic><topic>Bicarbonates - metabolism</topic><topic>Biological and medical sciences</topic><topic>Bombesin - pharmacology</topic><topic>Ceruletide - pharmacology</topic><topic>Cholecystokinin - antagonists &amp; inhibitors</topic><topic>Cholecystokinin - blood</topic><topic>Dogs</topic><topic>Eating - physiology</topic><topic>Exocrine pancreas</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gastric Acid - metabolism</topic><topic>Pancreas - enzymology</topic><topic>Proglumide - analogs &amp; derivatives</topic><topic>Proglumide - pharmacology</topic><topic>Proteins - metabolism</topic><topic>Vertebrates: digestive system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Jong, A J</creatorcontrib><creatorcontrib>Singer, M V</creatorcontrib><creatorcontrib>Jansen, J B</creatorcontrib><creatorcontrib>Niebel, W</creatorcontrib><creatorcontrib>Rovati, L C</creatorcontrib><creatorcontrib>Lamers, C B</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Jong, A J</au><au>Singer, M V</au><au>Jansen, J B</au><au>Niebel, W</au><au>Rovati, L C</au><au>Lamers, C B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>1991-02-01</date><risdate>1991</risdate><volume>32</volume><issue>2</issue><spage>215</spage><epage>219</epage><pages>215-219</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><eissn>1458-3288</eissn><coden>GUTTAK</coden><abstract>This study was undertaken to determine the role of cholecystokinin in pancreatic enzyme secretion stimulated by bombesin and a meal by (a) comparing the pancreatic enzyme output during bombesin infusion and after a meal to output during caerulein infusion and (b) comparing the inhibitory effect of the cholecystokinin-receptor antagonist lorglumide (CR-1409) on enzyme output in response to bombesin and food with the response to caerulein. Bombesin (90 pmol/kg per h) and caerulein (30 pmol/kg per h) were infused into seven dogs in doses giving similar plasma cholecystokinin peak increments as a meal (mean (SEM) 6.8 (0.8), 6.3 (1.2), and 5.7 (0.8) pM, respectively), together with either saline or 2 mg/kg per h of lorglumide. A background infusion of synthetic secretin 20.5 pmol/kg per h was given in each experiment. In addition, gastric acid secretion was determined in the experiments with bombesin and caerulein infusion. Pancreatic protein responses to bombesin (1231 (247) mg/h) and food (1430 (220) mg/h) were similar to the responses to caerulein (1249 (201) mg/h). Lorglumide inhibited pancreatic protein output during stimulation with bombesin by 60%, after the meal by 45%, and during caerulein infusion by 68%. Pancreatic bicarbonate output by bombesin, caerulein, and food was inhibited by lorglumide by 28%, 40%, and 38%, respectively. In contrast, lorglumide significantly increased gastric acid secretion from 1.12 to 7.98 mmol/h during bombesin infusion and from 0.52 to 7.62 mmol/h during caerulein infusion. In conclusion, cholecystokinin plays an important part in the stimulation of pancreatic enzyme secretion by bombesin and a meal in conscious dogs and it is involved in the regulation of gastric acid during stimulation by infusions of caerulein and bombesin.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>1864545</pmid><doi>10.1136/gut.32.2.215</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 1991-02, Vol.32 (2), p.215-219
issn 0017-5749
1468-3288
1458-3288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1378812
source Open Access: PubMed Central
subjects Animals
Bicarbonates - metabolism
Biological and medical sciences
Bombesin - pharmacology
Ceruletide - pharmacology
Cholecystokinin - antagonists & inhibitors
Cholecystokinin - blood
Dogs
Eating - physiology
Exocrine pancreas
Female
Fundamental and applied biological sciences. Psychology
Gastric Acid - metabolism
Pancreas - enzymology
Proglumide - analogs & derivatives
Proglumide - pharmacology
Proteins - metabolism
Vertebrates: digestive system
title Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A37%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20the%20cholecystokinin-receptor%20antagonist%20lorglumide%20on%20pancreatic%20enzyme%20secretion%20stimulated%20by%20bombesin,%20food,%20and%20caerulein,%20giving%20similar%20plasma%20cholecystokinin%20concentrations%20in%20the%20dog&rft.jtitle=Gut&rft.au=de%20Jong,%20A%20J&rft.date=1991-02-01&rft.volume=32&rft.issue=2&rft.spage=215&rft.epage=219&rft.pages=215-219&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.32.2.215&rft_dat=%3Cproquest_pubme%3E80725333%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b4225-89741b99ca04633ee711c1306131cd388a6eb32a7cfc4b80677fc4bc7d71ac283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1770062080&rft_id=info:pmid/1864545&rfr_iscdi=true